Posttranslational modifications of transthyretin are serum markers in patients with mycosis fungoides

Neoplasia

Volumn 9, Issue 3, 2007, Pages 254-259

  Escher, Niko ^a   Kaatz, Martin ^a   Melle, Christian ^a   Hipler, Christina ^a   Ziemer, Mirjana ^a   Driesch, Dominik ^b   Wollina, Uwe ^c   Von Eggeling, Ferdinand ^a,d  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b BIOCONTROL JENA GMBH   (Germany)

^c ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

^d Institut fur Humangenetik und Anthropologie   (Germany)

Author keywords

Mycosis fungoides (MF); ProteinChip arrays; SELDI; Transthyretin; Transthyretin modifications

Indexed keywords

PREALBUMIN; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; PROTEIN PROCESSING; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 33947430973     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.06805     Document Type: Article

References (28)

1. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, et al. (2005). WHO-EORTC classification for cutaneous lymphomas. Blood 105, 3768-3785.
2. Koh HK, Charif M, and Weinstock MA (1995). Epidemiology and clinical manifestations of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 9, 943-960.
3. Kari L, Loboda A, Nebozhyn M, Rook AH, Vonderheid EC, Nichols C, Virok D, Chang C, Horng WH, Johnston J, et al. (2003). Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. J Exp Med 197, 1477-1488.
4. Kim YH, Bishop K, Varghese A, and Hoppe RT (1995). Prognostic factors in erythrodermic mycosis fungoides and the Sezary syndrome. Arch Dermatol 131, 1003-1008.
5. Sakamoto FH, Colleoni GW, Teixeira SP, Yamamoto M, Michalany NS, Almeida FA, Chiba AK, Petri V, Fernandes MA, and Pombo-de-Oliveira MS (2006). Cutaneous T-cell lymphoma with HTLV-I infection: clinical overlap with adult T cell leukemia/lymphoma. Int J Dermatol 45, 447-449.
6. Knol AC, Guilloux Y, Quereux G, Marques-Briand S, Pandolfino MC, Khammari A, and Dreno B (2005). CD8(+) T lymphocytes reactive against Epstein-Barr virus antigens in skin lesions of a patient with Sezary syndrome. J Am Acad Dermatol 53, 897-900.
7. Hamerlinck FF, Toonstra J, and van Vloten WA (1999). Increased serum neopterin levels in mycosis fungoides and Sezary syndrome. Br J Dermatol 141, 1136-1137.
8. Hassel JC, Meier R, Joller-Jemelka H, Burg G, and Dummer R (2004). Serological immunomarkers in cutaneous T cell lymphoma. Dermatology 209, 296-300.
9. Bichler A, Fuchs D, Hausen A, Hetzel H, Reibnegger G, and Wachter H (1983). Measurement of urinary neopterin in normal pregnant and nonpregnant women and in women with benign and malignant genital tract neoplasms. Arch Gynecol 233, 121-130.
10. Hetzel H, Bichler A, Fuchs D, Hausen A, Reibnegger G, and Wachter H (1983). Significance of urinary neopterin in gynecological oncology: follow-up of patients with ovarian cancer. Cancer Detect Prev 6, 263-266.
11. 2-microglobulin is associated with acute renal allograft rejection. Am J Kidney Dis 47, 898-904.
12. Ryu OH, Atkinson JC, Hoehn GT, Illei GG, and Hart TC (2006). Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology (Oxford) 45, 1077-1086.
13. Xiao P, Chen QF, Yang YL, Guo ZH, and Chen H (2006). Serum soluble interleukin-2 receptor levels in patients with chronic hepatitis B virus infection and its relation with anti-HBc. World J Gastroenterol 12, 482-484.
14. Wadwa RP, Kinney GL, Ogden L, Snell-Bergeon JK, Maahs DM, Cornell E, Tracy RP, and Rewers M (2006). Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes. Int J Biochem Cell Biol 38, 996-1003.
15. Tracey L, Villuendas R, Dotor AM, Spiteri I, Ortiz P, Garcia JF, Peralto JL, Lawler M, and Piris MA (2003). Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study. Blood 102, 1042-1050.
16. - lymphocytes of patients with cutaneous T-cell lymphoma. Eur J Cancer 42, 249-255.
17. von Eggeling F, Davies H, Lomas L, Fiedler W, Junker K, Claussen U, and Ernst G (2000). Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research. Biotechniques 29, 1066-1070.
18. Melle C, Ernst G, Schimmel B, Bleul A, Koscielny S, Wiesner A, Bogumil R, Moller U, Osterloh D, Halbhuber KJ, et al. (2003). Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip(R) technology, two-dimensional gel electrophoresis, tandem mass spectrometry, and immunohistochemistry. Mol Cell Proteomics 2, 443-452.
19. Busch A, Michel S, Hoppe C, Driesch D, Claussen U, and Von EF (2005). Proteome analysis of maternal serum samples for trisomy 21 pregnancies using ProteinChip arrays and bioinformatics. J Histochem Cytochem 53, 341-343.
20. Kiendl H and Krabs M (1989). Ein Verfahren zur Generierung regelbasierter Modelle für dynamische Systeme. Automatisierungstechnik 37, 423-30.
21. Biroccio A, Del Boccio P, Panella M, Bernardini S, Di Ilio C, Gambi D, Stanzione P, Sacchetta P, Bernardi G, Martorana A, et al. (2006). Differential post-translational modifications of transthyretin in Alzheimer's disease: a study of the cerebral spinal fluid. Proteomics 6, 2305-2313.
22. Kagami S, Sugaya M, Minatani Y, Ohmatsu H, Kakinuma T, Fujita H, and Tamaki K (2006). Elevated serum CTACK/CCL27 levels in CTCL. J Invest Dermatol 126, 1189-1191.
23. Fung ET, Yip TT, Lomas L, Wang Z, Yip C, Meng XY, Lin S, Zhang F, Zhang Z, Chan DW, et al. (2005). Classification of cancer types by measuring variants of host response proteins using SELDI serum assays. Int J Cancer 115, 783-789.
24. Zhang Z, Bast RC Jr, Yu Y, Li J, Sokoll LJ, Rai AJ, Rosenzweig JM, Cameron B, Wang YY, Meng XY, et al. (2004). Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 64, 5882-5890.
25. Kozak KR, Su F, Whitelegge JP, Faull K, Reddy S, and Farias-Eisner R (2005). Characterization of serum biomarkers for detection of early stage ovarian cancer. Proteomics 5, 4589-4596.
26. Feng JT, Liu YK, Song HY, Dai Z, Qin LX, Almofti MR, Fang CY, Lu HJ, Yang PY, and Tang ZY (2005). Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics 5, 4581-4588.
27. Marten NW, Sladek FM, and Straus DS (1996). Effect of dietary protein restriction on liver transcription factors. Biochem J 317 (Pt 2), 361-370.
28. Sudeepa B, Bhattacharyya S, Siegel ER, Petersen GM, Chari ST, Suva LJ, and Haun RS (2004). Diagnosis of pancreatic cancer using serum proteomic profiling. Neoplasia 6, 674-686.